Delivery Order SPE2DB24D3013-SPE2DB24FFGKN

Award Date 7/24/24
Potential Completion Date 7/25/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Naltrexone 50 mg tablets. The contract has a total ceiling value of $12,406.98 and a performance period through November 26, 2024. It is a firm fixed price contract, meaning the price does not change regardless of the actual costs incurred by the contractor. The contract is not associated with any specific set-aside requirement, indicating open competition. Amerisourcebergen...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of Naltrexone 50 mg tablets in 90-count packages, with a ceiling value of $7,106.19 and a performance period through March 13, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Naltrexone 50 mg tablets, a medication used to treat opioid addiction. The contract is a firm-fixed price delivery order with a ceiling value of $7,192.66 and a period of performance ending on May 2, 2025. This order is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 60-count Naltrexone 50 mg tablets. The contract has a ceiling value of $5,187.32 and an ultimate completion date of August 16, 2024. The contract is a firm-fixed price delivery order, with no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Naltrexone 50 mg tablets. The contract has a ceiling value of $6,028.72 and a completion date of May 21, 2025. It was awarded on May 20, 2025 by the Defense Logistics Agency (DLA), a defense agency, as a firm fixed-price delivery order contract. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply 60-count bottles of 50 mg Naltrexone tablets. The $14,381.08 contract has a completion date of September 9, 2024 and was awarded on September 6, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen valued at up to $999,999,999 through December...
This is a $3,865.30 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 60-count bottles of 50 mg Naltrexone tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,556.55, is for the delivery of 4,568,088,986 units of the prescription medication Naltrexone 50 mg tablet. The contract has a performance period through May 1, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,018.51, is a delivery order for the supply of 4,566,295,719 units of Naltrexone 50 mg tablets. The contract is an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to provide Naltrexone 50 mg tablets. The $13,644 firm fixed-price Delivery Order has a completion date of November 14, 2024 and does not have a set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a comprehensive range of pharmaceutical products and...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB24FFGKN
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Naltrexone 50 mg tablets. The contract has a firm fixed price structure and a ceiling value of $2,412.07. It is not associated with any set-aside program. The award is a part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities, including pharmaceuticals, to support military treatment programs and facilities worldwide.

Generated 10/23/24, 9:41 AM